Vertex Pharmaceuticals (VRTX) Times Interest Earned (2018 - 2025)
Historic Times Interest Earned for Vertex Pharmaceuticals (VRTX) over the last 10 years, with Q3 2025 value amounting to $359.45.
- Vertex Pharmaceuticals' Times Interest Earned rose 14150.4% to $359.45 in Q3 2025 from the same period last year, while for Sep 2025 it was $311.98, marking a year-over-year increase of 453054.73%. This contributed to the annual value of -$7.61 for FY2024, which is 10875.91% down from last year.
- Per Vertex Pharmaceuticals' latest filing, its Times Interest Earned stood at $359.45 for Q3 2025, which was up 14150.4% from $311.11 recorded in Q2 2025.
- In the past 5 years, Vertex Pharmaceuticals' Times Interest Earned ranged from a high of $366.43 in Q4 2024 and a low of -$355.02 during Q2 2024
- In the last 3 years, Vertex Pharmaceuticals' Times Interest Earned had a median value of $129.2 in 2024 and averaged $143.05.
- Data for Vertex Pharmaceuticals' Times Interest Earned shows a peak YoY increase of 29293.3% (in 2024) and a maximum YoY decrease of 48739.54% (in 2024) over the last 5 years.
- Over the past 3 years, Vertex Pharmaceuticals' Times Interest Earned (Quarter) stood at $93.25 in 2023, then surged by 292.93% to $366.43 in 2024, then dropped by 1.9% to $359.45 in 2025.
- Its Times Interest Earned stands at $359.45 for Q3 2025, versus $311.11 for Q2 2025 and $210.03 for Q1 2025.